XML 19 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total Shareholders' Equity
Common Shares
Additional Paid in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Noncontrolling Interest in Subsidiaries
Noncontrolling Interests in the Operating Partnership
Total
Balance at Dec. 31, 2022 $ 2,826,203 $ 2,246 $ 4,125,478 $ (491) $ (1,301,030) $ 14,178   $ 2,840,381
Balance (in shares) at Dec. 31, 2022   224,603            
Balance of Noncontrolling Interests in the Operating Partnership at Dec. 31, 2022             $ 57,419  
Increase (Decrease) in Stockholders' Equity                
Distributions paid to noncontrolling interest in subsidiaries           (107)   (107)
Issuance of common shares, net (91)   (91)         (91)
Issuance of restricted shares (in shares)   22            
Conversion from units to shares 361   361       (361) 361
Conversion from units to shares (in shares)   8            
Exercise of stock options 915 $ 1 914         915
Exercise of stock options (in shares)   39            
Amortization of restricted shares 1,171   1,171         1,171
Share compensation expense 730   730         730
Adjustment for noncontrolling interests in the Operating Partnership (8,588)       (8,588)   8,588 (8,588)
Net income (loss) 97,566       97,566 (238)   97,328
Net income (loss)             614  
Other comprehensive income (loss), net 20     20       20
Common share distributions (110,524)       (110,524)   (695) (110,524)
Balance at Mar. 31, 2023 2,807,763 $ 2,247 4,128,563 (471) (1,322,576) 13,833   2,821,596
Balance (in shares) at Mar. 31, 2023   224,672            
Balance of Noncontrolling Interests in the Operating Partnership at Mar. 31, 2023             65,565  
Increase (Decrease) in Stockholders' Equity                
Contributions from noncontrolling interest in subsidiaries           797   797
Distributions paid to noncontrolling interest in subsidiaries           (54)   (54)
Issuance of common shares, net (55)   (55)         (55)
Issuance of restricted shares (in shares)   20            
Exercise of stock options 1,801 $ 1 1,800         1,801
Exercise of stock options (in shares)   105            
Amortization of restricted shares 1,621   1,621         1,621
Share compensation expense 692   692         692
Adjustment for noncontrolling interests in the Operating Partnership 2,134       2,134   (2,134) 2,134
Net income (loss) 97,879       97,879 (212)   97,667
Net income (loss)             616  
Other comprehensive income (loss), net 20     20       20
Common share distributions (110,585)       (110,585)   (695) (110,585)
Balance at Jun. 30, 2023 2,801,270 $ 2,248 4,132,621 (451) (1,333,148) 14,364   2,815,634
Balance (in shares) at Jun. 30, 2023   224,797            
Balance of Noncontrolling Interests in the Operating Partnership at Jun. 30, 2023             63,352  
Balance at Dec. 31, 2023 2,798,828 $ 2,249 4,142,229 (411) (1,345,239) 21,704   2,820,532
Balance (in shares) at Dec. 31, 2023   224,921            
Balance of Noncontrolling Interests in the Operating Partnership at Dec. 31, 2023             60,276 60,276
Increase (Decrease) in Stockholders' Equity                
Contributions from noncontrolling interest in subsidiaries           309   309
Distributions paid to noncontrolling interest in subsidiaries           (125)   (125)
Issuance of common shares, net (10)   (10)         (10)
Issuance of restricted shares 1 $ 1           1
Issuance of restricted shares (in shares)   24            
Conversion from units to shares 561   561       (561) 561
Conversion from units to shares (in shares)   12            
Exercise of stock options 201   201         201
Exercise of stock options (in shares)   8            
Amortization of restricted shares 1,189   1,189         1,189
Share compensation expense 802   802         802
Adjustment for noncontrolling interests in the Operating Partnership 1,346       1,346   (1,346) 1,346
Net income (loss) 94,527       94,527 (210)   94,317
Net income (loss)             541  
Other comprehensive income (loss), net 20     20       20
Common share distributions (115,357)       (115,357)   (657) (115,357)
Balance at Mar. 31, 2024 2,782,108 $ 2,250 4,144,972 (391) (1,364,723) 21,678   2,803,786
Balance (in shares) at Mar. 31, 2024   224,965            
Balance of Noncontrolling Interests in the Operating Partnership at Mar. 31, 2024             58,253  
Increase (Decrease) in Stockholders' Equity                
Distributions paid to noncontrolling interest in subsidiaries           (54)   (54)
Issuance of common shares, net (39)   (39)         (39)
Issuance of restricted shares (in shares)   28            
Conversion from units to shares 2,123 $ 1 2,122       (2,123) 2,123
Conversion from units to shares (in shares)   50            
Exercise of stock options 4,518 $ 1 4,517         4,518
Exercise of stock options (in shares)   154            
Amortization of restricted shares 1,897   1,897         1,897
Share compensation expense 800   800         800
Adjustment for noncontrolling interests in the Operating Partnership 93       93   (93) 93
Net income (loss) 93,964       93,964 (302)   93,662
Net income (loss)             524  
Other comprehensive income (loss), net 20     20       20
Common share distributions (115,390)       (115,390)   (631) (115,390)
Balance at Jun. 30, 2024 $ 2,770,094 $ 2,252 $ 4,154,269 $ (371) $ (1,386,056) $ 21,322   2,791,416
Balance (in shares) at Jun. 30, 2024   225,197            
Balance of Noncontrolling Interests in the Operating Partnership at Jun. 30, 2024             $ 55,930 $ 55,930